CLRB - .749 Pre-market now at 10.80/12.00 WOW!!!!!! Cellectar Reports 94% Reduction in Overall Tumor Volume in Waldenstrom Macroglobulinemia Patient in Phase 2 CLR 131 Clinical Study http://stockcharts.com/c-sc/sc?s=CLRB&p=D&b=5&g=0&i=t88035491108&r=1531829099145